Natriuretic peptides stimulate cyclic guanosine monophosphate production in human saphenous vein and internal mammary artery

European Journal of Cardio-thoracic Surgery

Volumn 17, Issue 2, 2000, Pages 175-181

  Bonatti, Johannes ^a   Dichtl, Wolfgang ^a   Lercher, Angelika ^b   Puschendorf, Bernd ^b  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Coronary artery bypass; Internal mammary artery; Natriuretic peptides; Saphenous vein

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CYCLIC GMP; IODINE 125; NATRIURETIC PEPTIDE TYPE C; URODILATIN;

ARTICLE; CELL LEVEL; CELL SECRETION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; HUMAN; HUMAN TISSUE; INTERNAL MAMMARY ARTERY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SAPHENOUS VEIN; TISSUE SPECIFICITY;

ATRIAL NATRIURETIC FACTOR; CYCLIC GMP; HUMANS; MAMMARY ARTERIES; NATRIURETIC PEPTIDE, BRAIN; NATRIURETIC PEPTIDE, C-TYPE; PEPTIDE FRAGMENTS; SAPHENOUS VEIN;

EID: 0034144480     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(99)00339-5     Document Type: Article

References (25)

1. Yang Z., Oemar B., Luscher T.F. Mechanism of coronary bypass graft disease. Schweiz Med Wochenschr. 123:1993;422-427.
2. Luscher T.F., Diederich D., Siebenmann R., Lehmann K., Stulz P., von Segesser L., Yang Z.H., Turina M., Gradel E., Weber E., Buhler F.R. Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. N Engl J Med. 319:1988;462-467.
3. Chaikhouni A., Crawford F.A., Kochel P.J., Olanoff L.S., Halushka P.V. Human internal mammary artery produces more prostacyclin than saphenous vein. J Thorac Cardiovasc Surg. 92:1986;88-91.
4. Aardal S., Helle K.B., Svendsen E. In vitro responses to atrial natriuretic polypeptide in human vessels commonly used as aortocoronary bypass grafts. Scand J Thorac Cardiovasc Surg. 26:1992;135-141.
5. Ikeda T., Itoh H., Komatsu Y., Hanyu M., Yoshimasa T., Matsuda K., Nakao K., Ban T. Natriuretic peptide receptors in human artery and vein and rabbit vein graft. Hypertension. 27:1996;833-837.
6. Zhang L.M., Castresana M.R., McDonald M.H., Johnson J.H., Newman W.H. Response of human artery, vein, and cultured smooth muscle cells to atrial and C-type natriuretic peptides. Crit Care Med. 24:1996;306-310.
7. Bonatti J., Dichtl W., Dworzak E.A., Antretter H., Unger F., Puschendorf B., Dapunt O.E. Atrial natriuretic peptide-induced release of cyclic guanosine monophosphate by coronary bypass grafts. Ann Thorac Surg. 65:1998;1621-1624.
8. Meyer M., Richter R., Forssmann W.G. Urodilatin, a natriuretic peptide with clinical implications. Eur J Med Res. 3:1998;103-110.
9. de Bold A.J., Borenstein H.B., Veress A.T., Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci. 28:1981;89-94.
10. Flynn T.G., Davies P.L. The biochemistry and molecular biology of atrial natriuretic factor. Biochem J. 232:1985;313-321.
11. Kaneko T., Shirakami G., Nakao K., Nagata I., Nakagawa O., Hama N., Suga S., Miyamoto S., Kubo H., Hirai O., Kikuchi H., Imura H. C-type natriuretic peptide (CNP) is the major natriuretic peptide in human cerebrospinal fluid. Brain Res. 612:1993;104-109.
12. Furuya M., Yoshida M., Hayashi Y., Ohnuma N., Minamino N., Kangawa K., Matsuo H. C-type natriuretic peptide is a growth inhibitor of rat vascular smooth muscle cells. Biochem Biophys Res Commun. 177:1991;927-931.
13. Furuya M., Miyazaki T., Honbou N., Kawashima K., Ohno T., Tanaka S., Kangawa K., Matsuo H. C-type natriuretic peptide inhibits intimal thickening after vascular injury. Ann N Y Acad Sci. 748:1995;517-523.
14. Suga S., Nakao K., Itoh H., Komatsu Y., Ogawa Y., Hama N., Imura H. Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of 'vascular natriuretic peptide system'. J Clin Invest. 90:1992;1145-1149.
15. Schulz Knappe P., Forssmann K., Herbst F., Hock D., Pipkorn R., Forssmann W.G. Isolation and structural analysis of 'urodilatin', a new peptide of the cardiodilatin-(ANP)-family, extracted from human urine. Klin Wochenschr. 66:1988;752-759.
16. Brandt R.R., Heublein D.M., Mattingly M.T., Pittelkow M.R., Burnett J.C. Jr. Presence and secretion of atrial natriuretic peptide from cultured human aortic endothelial cells. Am J Physiol. 268:1995;H921-H925.
17. Drewett J.G., Garbers D.L. The family of guanylyl cyclase receptors and their ligands. Endocr Rev. 15:1994;135-162.
18. Okumura K., Yasue H., Fujii H., Kugiyama K., Matsuyama K., Yoshimura M., Jougasaki M., Kikuta K., Kato H., Tanaka H., Sumida H., Nakao K. Effects of brain (B-type) natriuretic peptide on coronary artery diameter and coronary hemodynamic variables in humans: comparison with effects on systemic hemodynamic variables. J Am Coll Cardiol. 25:1995;342-348.
19. Honkonen E.L., Kaukinen L., Pehkonen E.J., Kaukinen S. Atrial natriuretic peptide and N-terminal atrial natriuretic peptide in plasma reflect right ventricular volumes following coronary artery surgery. Acta Anaesthesiol Scand. 41:1997;685-693.
20. Hedner J., Towle A., Saltzman L., Mueller R.A., Norfleet E.A., Watson C.B., Hedner T. Changes in plasma atrial natriuretic peptide-immunoreactivity in patients undergoing coronary artery bypass graft placements. Regul Pept. 17:1987;151-157.
21. Wambach G., Hannekum A., Schmidt S., Kaufmann W., Dalichau H. Increased concentrations of atrial natriuretic peptide in the plasma and heart atrium of patients with aortic and mitral valve diseases compared to patients with coronary heart disease. Z Kardiol. 76:1987;76-80.
22. Hughes A.D., Thom S.A., Martin G.N., Nielsen H., Hair W.M., Schachter M., Sever P.S., Hughes A., Thom S. Size and site-dependent heterogeneity of human vascular responses in vitro. Direct effect of alpha-human atrial natriuretic peptide on human vasculature in vivo and in vitro. J Hypertens. 74:(Suppl):1988;207-211.
23. Protter A.A., Wallace A.M., Ferraris V.A., Weishaar R.E. Relaxant effect of human brain natriuretic peptide on human artery and vein tissue. Am J Hypertens. 9:1996;432-436.
24. Oie B.K., Myking O., Hoff P.I., Ohm O.J. The acute effects of induced tachycardia on coronary sinus and arterial plasma levels of atrial natriuretic peptide and on arterial catecholamines. Scand J Clin Lab Invest. 54:1994;155-159.
25. Wei C.M., Aarhus L.L., Miller V.M., Burnett J.C. Jr. Action of C-type natriuretic peptide in isolated canine arteries and veins. Am J Physiol. 264:1993;H71-H73.